SpliceBio
PrivateLast Round
Series B
Jun 11, 2025
Total Funding Raised
$192.34M
Company Overview
SpliceBio is a biotechnology company that develops genetic medicines through its proprietary Protein Splicing gene therapy platform, enabling the delivery of larger cargo genes for the treatment of incurable genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpliceBio Comparables
Compare SpliceBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AAVantgarde Bio | 94% | |
| Scriptr Global, Inc. | 83% | |
| Atsena Therapeutics | 82% | |
SpliceBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 11, 2025 | ||||
| Series A | Feb 16, 2022 | ||||
| Grant | Dec 10, 2020 | ||||
| Seed | Sep 15, 2020 |
SpliceBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series B, Series A, Seed |
| UCB Ventures | Series A, Series B |
| Roche Venture Fund | Series B |
| EQT Life Sciences | Series B |
| New Enterprise Associates (NEA) | Series A, Series B |
| Ysios Capital | Series B, Seed, Series A |
| UCB Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
Proprietary platform based on Princeton University's Muir Lab technology.
- Jun 11, 2025
$135M round completed.
SpliceBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SpliceBio's valuation, stock price, and market status.